LianJin Bio
联进生物
LianJin Bio
Biotech/Healthcare
Lianjin Bio is an innovative biotechnology company focused on the research and development of targeted drug conjugates. It owns multiple proprietary technologies, including Smart TME Activated Release (STAR), and has built three technology platforms covering bispecific antibody-drug conjugates…
Latest round: Series A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-10-13
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.